Bio-Botanica Inc., a family-owned and operated company, specializing in botanicals for over 45 years and headquartered in Hauppage (New York), has partnered with U.S. biotech company Genomatica to create a new line of botanical extracts using a naturally sourced, sustainably produced butylene glycol. These products, manufactured by Bio- Botanica Inc., feature Genomatica’s proprietary ingredient, Brontide.
Italy-based Aquafil and Californian biotech company Genomatica join forces to create sustainable caprolactam, a key ingredient to producing 100% sustainable nylon. The collaboration between the two companies aims to develop a commercially-advantageous bioprocess (Genomatica’s GENO CPL process) to make caprolactam using plant-based renewable ingredients, rather than the crude oil-derived materials traditionally used by the nylon industry.
Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.
The bio-butadiene (bio-BDE) technology developed by Versalis (Eni) in partnership with Genomatica has been named winner of the Environmental Achievement of the Year within the “Tire Technology International Awards for Excellence and Innovation”, the European independent award program for the tire industry.
“Biotech is becoming increasingly important to the mainstream chemical industry as the demand for more sustainable solutions intensifies. Biotech is especially well-suited to help with some of the industry’s biggest challenges”. To say it – in this exclusive interview with Il Bioeconomista – is Christophe Schilling, founder and CEO of Genomatica, a widely-recognized bioengineering leader for the chemical industry. The San Diego-based biotechnology company develops and licenses bio-based manufacturing processes for the production of intermediate and basic chemicals.
Since being named CEO in May 2009, Christophe Schilling has led Genomatica to widespread recognition as a leader in industrial biotechnology, with a commercialized first process, top-tier licensees, strong investors and an unrivaled string of awards for engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest three years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Schilling frequently speaks on industry trends at major conferences and serves as a member of the World Economic Forum Global Agenda Council on Biotechnology.
Interview by Mario Bonaccorso
Ginkgo Bioworks and Genomatica announced an alliance to more rapidly deliver biology-based solutions for the world’s highest-volume intermediate and specialty chemicals. Mainstream chemical producers can now in-license technology to manufacture their widely-used chemicals with cost-effective and sustainable whole-process solutions that include engineered microorganisms, complete process designs and technology transfer support. The alliance is structured as a deep collaboration, with two-way sharing of technology and intellectual property, along with joint technology development, to provide a single unified offering to the market.
Mater Biotech, a 100% company owned by Novamont, today proved Genomatica’s revolutionary technology that converts renewable feedstocks into 1,4 butendiol (BDO) at the Grand Opening of its first commercial bio-BDO plant in Bottrighe di Adria (Rovigo, Italy).
Novamont’s bio-based butanediol (BDO) plant in Bottrighe di Adria (Veneto, North-eastern Italy), established as a joint venture (Mater Biotech) with San Diego-based Genomatica and now entirely controlled by the company headquartered in Novara, will come on stream by the end of September. It is a big step forward for the Italian bioeconomy, which is confirmed in its leading role in Europe.
BASF and Genomatica have expanded the scope of their license agreement for the production of 1,4-butanediol based on renewable feedstock (renewable BDO) using Genomatica’s patented process. The parties added certain countries in Southeast Asia to their initial agreement, which focused on North America.
Genomatica and Cargill have entered into a collaboration agreement to accelerate the production of renewable chemicals for industrial applications. The collaboration will give chemical producers, distributors and users access to a reliable, cost-effective source of carbohydrate feedstocks, co-location support services and production partnerships, based on GENO™ process technologies.